巨细胞-T淋巴细胞轴影响癌症:朋友还是敌人?
Vinicius Kannen1, Denis M Grant1, Jason Matthews2
1Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.
Cancer letters
|March 10, 2024
概括
巨细胞 (MCs) 和T淋巴细胞 (TLs) 在癌症中起着复杂的作用,影响瘤的发展和破坏. 调节MC可以增强用于癌症治疗的基于TL的免疫疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 巨细胞 (MCs) 和T淋巴细胞 (TLs) 在癌症中表现出双重作用,可能促进瘤生长或调解抗癌免疫力.
- 它们在瘤微环境中的复杂相互作用和信号通路对于癌症的进展和免疫规避至关重要.
- 在癌症中准MC-TL交叉声的治疗潜力往往被低估.
研究的目的:
- 在癌症的背景下阐明巨细胞和T淋巴细胞之间的复杂关系.
- 探索调节巨细胞活性以增强T细胞介导的抗癌反应的潜力.
- 突出MC-TL相互作用在开发新型癌症免疫疗法的重要性.
主要方法:
- 关于实体瘤中巨细胞-T淋巴细胞相互作用的最新科学文献的综述.
- 分析参与MC-TL交叉通话的信号通路及其对瘤免疫力的影响.
- 检查新兴的治疗策略,包括药理调制和细胞疗法.
主要成果:
- 巨细胞激活可以影响癌症的发展,而透瘤的T淋巴细胞可能会导致侵袭性疾病.
- 乳腺细胞调节固体瘤内的T淋巴细胞活性,呈现出潜在的治疗标.
- 巨细胞的药理调节可以增强细胞毒性T淋巴细胞对瘤的反应.
结论:
- 乳腺细胞-T淋巴细胞相互作用是癌症免疫和进展的关键.
- 向巨细胞活动代表了增强基于T淋巴细胞的癌症免疫疗法的有希望的策略.
- 涉及T淋巴细胞和乳腺细胞的工程细胞疗法显示出治疗癌症的潜力.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
T Cell Activation and Clonal Selection
731
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
731
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524


